Natarajan Aravindan

Dr. Aravindan is a Professor and Kerr Chair in the Department of Physiological Sciences within the College of Veterinary Medicine at Oklahoma State University. He has over 25 years of experience in Molecular Oncology and Radiation Biology/Oncology, including 20 years of experience in administration of multidisciplinary education, research, and training programs. Dr. Aravindan is the founding leader for the OSU’s comprehensive “All-of-Us Research & Education Program,” the entity that nurture research collaboration, productivity, mentorship and grantsmanship. Dr. Aravindan obtained his PhD degree in Microbiology from Andhra University, Visakhapatnam, India and earned his fellowship in Radiation Oncology from the University of Texas Health Sciences Center at San Antonio and, in Cancer Critical Care Medicine from UT-M.D. Anderson Cancer center, Houston, Tx. Dr. Aravindan research primarily focuses on fingerprinting molecular and cellular signaling in cancer as well in normal tissues and includes research in tumor evolution, molecular target discovery, and pre-clinical drug development. His laboratory develops original models for tumorigenesis and disease evolution, is actively involved in preclinical, bed-to-bench and translational studies. He has authored more than 90 peer-reviewed publications of original research, 220 peer-reviewed published abstracts, 100 scientific presentations and 50 plenary session / invited lectures. He works with undergraduate, college, graduate students, post-doctoral fellows, and faculty on a day-to-day basis, and have been principal advisor for many Ph.D. graduates and served on advisory committees for dozens more across multiple departments and disciplines. He is an active member of Cancer Biology Program in Oklahoma NCI-Designated Stephenson Cancer Center, and member of many international cancer and radiation research scientific communities. He has received numerous awards in recent years, including the Williams Company Foundation Presidential Professorship, Educators for Excellence award, Scientific Achievement Award to name a few. Dr. Aravindan also serves in innumerable federal, NIH, NCI, DOD, DMRDP; international, la Caix, NWO/ZonMw, FCT, OTKA and institutional scientific review panels. He is interested in translating research to improve One health. He is a keen supporter of One Medicine as his own work is fueled by the desire to create therapeutics that will eventually improve animal and human health.

Research Interests:

Some of the Dr. Aravindan’s research interests are: 1) acquired genetic modifications with therapy pressure; 2) development of molecular-targeted tumor targeted maintenance therapy; 3) bystander and abscopal effects of tumor radiotherapy; 4) cold tumors and mechanisms of tumor immune evasion; 5) space radiation carcinogenesis and cardiovascular complications.